Atlas Trials

Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia

Clinical trial NCT00852566 · COMPLETED

Trial details

NCT number
NCT00852566
Sponsor
Norwegian University of Science and Technology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2009-03-01
Primary completion
2011-02-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.